BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 6363395)

  • 1. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
    Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
    J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol and reduced haloperidol concentrations in plasma and red blood cells from chronic schizophrenic patients.
    Ko GN; Korpi ER; Kirch DG
    J Clin Psychopharmacol; 1989 Jun; 9(3):186-90. PubMed ID: 2661607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol blood levels and effects in schizophrenia and schizoaffective disorder: a progress report.
    Volavka J; Cooper TB; Meisner M; Bitter I; Czobor P; Jaeger J
    Psychopharmacol Bull; 1990; 26(1):13-7. PubMed ID: 2371368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acutely psychotic patients receiving high-dose haloperidol therapy.
    Remington G; Pollock B; Voineskos G; Reed K; Coulter K
    J Clin Psychopharmacol; 1993 Feb; 13(1):41-5. PubMed ID: 8486816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of neuroleptic blood levels in the treatment of acute psychosis.
    Zohar J; Shemesh Z; Belmaker RH
    J Clin Psychiatry; 1986 Dec; 47(12):600-3. PubMed ID: 3782046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haloperidol decanoate pharmacokinetics in red blood cells and plasma.
    Dysken MW; Kim SW; Vatassery G; Johnson SB; Skare S; Holden L; Thomsyck L
    J Clin Psychopharmacol; 1992 Apr; 12(2):128-32. PubMed ID: 1573034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative efficacy of parenteral haloperidol and thiothixene for the emergency treatment of acutely excited and agitated patients.
    Stotsky BA
    Dis Nerv Syst; 1977 Dec; 38(12):967-73. PubMed ID: 338270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
    Chouinard G; Safadi G; Beauclair L
    J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
    Tuason VB
    J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of injectable molindone and haloperidol followed by oral dosage forms in acutely ill schizophrenics.
    Escobar JI; Mann JJ; Keller J; Wilkins J; Mason B; Mills MJ
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):15-9. PubMed ID: 3894337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RBC and plasma levels of haloperidol and clinical response in schizophrenia.
    Smith RC; Vroulis G; Shvartsburd A; Allen R; Lewis N; Schoolar JC; Chojnacki M; Johnson R
    Am J Psychiatry; 1982 Aug; 139(8):1054-6. PubMed ID: 7091432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind randomized clinical trial of rapid tranquilization with I.M. clonazepam and I.M. haloperidol in agitated psychotic patients with manic symptoms.
    Chouinard G; Annable L; Turnier L; Holobow N; Szkrumelak N
    Can J Psychiatry; 1993 Nov; 38 Suppl 4():S114-21. PubMed ID: 8306241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia.
    Reschke RW
    Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness of oral and parenteral rapid neuroleptization.
    Coffman JA; Nasrallah HA; Lyskowski J; McCalley-Whitters M; Dunner FJ
    J Clin Psychiatry; 1987 Jan; 48(1):20-4. PubMed ID: 3542982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood levels of haloperidol and clinical outcome in schizophrenia.
    Doddi S; Rifkin A; Karajgi B; Cooper T; Borenstein M
    J Clin Psychopharmacol; 1994 Jun; 14(3):187-95. PubMed ID: 8027415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Droperidol vs. haloperidol in the initial management of acutely agitated patients.
    Resnick M; Burton BT
    J Clin Psychiatry; 1984 Jul; 45(7):298-9. PubMed ID: 6376480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid tranquilization: a comparison of thiothixene with loxapine.
    Dubin WR; Weiss KJ
    J Clin Psychiatry; 1986 Jun; 47(6):294-7. PubMed ID: 3711026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haloperidol in acute schizophrenic inpatients. A double-blind comparison of two dosage regimens.
    Modestin J; Toffler G; Pia M; Greub E
    Pharmacopsychiatria; 1983 Jul; 16(4):121-6. PubMed ID: 6356177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.